Cryptococcus neoformans cells in biofilms are less susceptible than planktonic cells to antimicrobial molecules produced by the innate immune system.
about
Susceptibility of Pneumocystis to echinocandins in suspension and biofilm culturesAdvances in microbial biofilm prevention on indwelling medical devices with emphasis on usage of acoustic energyAntibody-mediated immobilization of Cryptococcus neoformans promotes biofilm formation.Biofilm formation by Cryptococcus neoformans under distinct environmental conditions.Capsule enlargement in Cryptococcus neoformans confers resistance to oxidative stress suggesting a mechanism for intracellular survival.In Vitro Activity of Miltefosine against Candida albicans under Planktonic and Biofilm Growth Conditions and In Vivo Efficacy in a Murine Model of Oral CandidiasisCryptococcus neoformans biofilm formation depends on surface support and carbon source and reduces fungal cell susceptibility to heat, cold, and UV lightFungal Biofilms: In Vivo Models for Discovery of Anti-Biofilm DrugsExtracellular DNA within a nontypeable Haemophilus influenzae-induced biofilm binds human beta defensin-3 and reduces its antimicrobial activity.Methamphetamine enhances Cryptococcus neoformans pulmonary infection and dissemination to the brain.The use of chitosan to damage Cryptococcus neoformans biofilms.Our current understanding of fungal biofilms.Candida albicans prosthetic hip infection in elderly patients: is fluconazole monotherapy an option?Variability of phenotypic traits in Cryptococcus varieties and species and the resulting implications for pathogenesis.Mechanisms of cryptococcal virulence and persistence.Fungal Biofilms: Relevance in the Setting of Human Disease.Baker's yeast as a tool for the development of antifungal drugs which target cell integrity - an update.Methods for obtaining reliable and reproducible results in studies of Candida biofilms formed in vitro.Cryptococcosis: epidemiology, fungal resistance, and new alternatives for treatment.The Extracellular Matrix of Fungal Biofilms.Virulence of Cryptococcus sp. Biofilms In Vitro and In Vivo using Galleria mellonella as an Alternative ModelThe Naturally Occurring Host Defense Peptide, LL-37, and Its Truncated Mimetics KE-18 and KR-12 Have Selected Biocidal and Antibiofilm Activities Against Candida albicans, Staphylococcus aureus, and Escherichia coli In vitro.EDTA inhibits biofilm formation, extracellular vesicular secretion, and shedding of the capsular polysaccharide glucuronoxylomannan by Cryptococcus neoformans.Characterization of phenotypic switching in Cryptococcus neoformans biofilms.aBiofilm: a resource of anti-biofilm agents and their potential implications in targeting antibiotic drug resistance.The Crucial Role of Biofilms in Cryptococcus neoformans Survival within Macrophages and Colonization of the Central Nervous System.Fungal Strategies to Evade the Host Immune Recognition.The Interface between Fungal Biofilms and Innate Immunity.Fungal Biofilms and Polymicrobial Diseases.Geometrical Distribution of Cryptococcus neoformans Mediates Flower-Like Biofilm Development.
P2860
Q28477349-38DA5995-E431-4083-9FCF-ABFAFBAF7DBAQ30467753-5B6BE183-9DDF-4D55-AE15-090A34F5100AQ30487314-7AD9D7DC-D97D-47FE-BC45-716EA658C558Q34781743-7556AADE-FE73-4830-912B-10AFF99FAB38Q35512999-63A82A26-020C-492C-99C1-050C784E251DQ35791192-54FF8B58-38A9-4037-8745-1BBFE89ABA7DQ35913297-53D77EAD-A04A-4D5E-B395-D4FF72ABC052Q36089061-3885C030-5D6B-4A1A-B68F-6C31D52766C9Q36807266-F218A38D-6D56-4231-8228-E8FC9D7C7992Q37074706-32D0957C-E86B-4BA9-A8ED-A3918B1B49B0Q37438897-913A5789-B9DF-4876-8285-BD1F4EB75FDAQ37622959-A5E48E79-9640-4C3F-98B8-C5C3F6705CDFQ37670259-7850207D-76B9-45C7-B9F1-28F31CF2254AQ37742176-4DFE8C55-DC3B-47EA-94EE-59C4C625E1F4Q37781066-891FD649-067A-4A09-B11F-17694EE69641Q37887512-4371AFAD-B804-4727-B7E4-18A01127351FQ38088803-0CA2EBF9-7DF6-4C06-9577-B711D0470B70Q38109647-CDE2C357-7FB2-45AA-871C-10B70E1B7D64Q38154164-85AD9CC9-81ED-4C00-BE1C-A00B802EF561Q38856993-9410B657-4C05-4B3C-BC18-3A9CB3B8B48AQ38858709-0B0F0743-AD1D-42A2-9EC0-1DAC577518FFQ40251230-06D366B4-43FD-48BF-8B4F-5F74506AABBDQ41588074-EAE63804-7D5F-48A0-968C-1A450CB508C3Q43077543-4ABC09F6-0A6E-47A3-9297-81EBFCE85D03Q47100874-42A59EFD-7F3C-41F4-A7A4-743A339B04F2Q47839060-141EFE1B-9927-4ECF-92F2-CD2906722F24Q48163110-729CD7D7-7B60-45B9-8744-A5426C921E7EQ49203638-061B52AC-F49B-4198-B8AC-C28AEEC374E2Q49679766-96E1B29D-9D4D-4099-BE81-F035F3EF390CQ50130646-3C483C55-51CC-410B-9A27-56A45AD6E936
P2860
Cryptococcus neoformans cells in biofilms are less susceptible than planktonic cells to antimicrobial molecules produced by the innate immune system.
description
2006 nî lūn-bûn
@nan
2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Cryptococcus neoformans cells ...... d by the innate immune system.
@ast
Cryptococcus neoformans cells ...... d by the innate immune system.
@en
type
label
Cryptococcus neoformans cells ...... d by the innate immune system.
@ast
Cryptococcus neoformans cells ...... d by the innate immune system.
@en
prefLabel
Cryptococcus neoformans cells ...... d by the innate immune system.
@ast
Cryptococcus neoformans cells ...... d by the innate immune system.
@en
P2860
P356
P1476
Cryptococcus neoformans cells ...... d by the innate immune system.
@en
P2093
Luis R Martinez
P2860
P304
P356
10.1128/IAI.00995-06
P407
P577
2006-11-01T00:00:00Z